T1	p 63 125	asthma due to house dust mite Dermatophagoides pteronyssinus :
T2	p 295 318	house dust mite ( HDM )
T3	p 387 421	10 patients with asthma due to HDM
T4	p 458 474	patients ( Group
T5	p 533 553	5 patients ( Group B
T6	i 6 59	Local immunotherapy by inhalation of a powder extract
T7	i 93 123	Dermatophagoides pteronyssinus
T8	i 157 183	parenteral immunotherapy .
T9	i 231 320	local immunotherapy ( LI ) by inhalation of a powder extract of house dust mite ( HDM ) ,
T10	i 335 389	with parenteral immunotherapy ( PI ) by injection , 10
T11	i 404 410	asthma
T12	i 418 421	HDM
T13	i 489 534	LI and subcutaneous injections of placebo , 5
T14	i 566 609	PI and inhalation of lactose for 6 months .
T15	i 657 670	premedication
T16	i 676 699	disodium cromoglycate (
T17	i 1079 1094	distilled water
T18	o 756 826	symptoms score and in peak expiratory flow ( PEF ) -derived parameters
T19	o 902 916	late component
T20	o 924 942	bronchial response
T21	o 1111 1130	immunologic humoral
T22	o 1218 1245	important adverse reactions
T23	o 1278 1299	systemic side effects
T24	o 1398 1404	action
T25	o 1477 1486	tolerated